Stay Informed

Filter

Filter By

Reference Type

Author

Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: a systematic review

2018

van Abbema, D.L.; van den Akker, M.; Janssen-Heijnen, M.L.; van den Berkmortel, F.; Hoeben, A.; de Vos-Geelen, J.; Buntinx, F.; Kleijnen, J.; Tjan-Heijnen, V.C.G.

J Geriatr Oncol; 10: 31-41.

Read More

What’s up, doc? The latest news on finding reviews

2018

Kleijnen, J.

JBI Database of Systematic Reviews and Implementation Reports; 16: 1284-5.

Read More

Ticagrelor for secondary prevention of atherothrombotic events after myocardial infarction: an Evidence Review Group perspective of a NICE single technology appraisal

2018

Pouwels, X.G.L.V.; Wolff, R.; Ramaekers, B.L.T.; Van Giessen, A.; Lang, S.; Ryder, S.; Worthy, G.; Duffy, S.; Armstrong, N.; Kleijnen, J.; Joore, M.A.

Pharmacoeconomics; 36: 533-43.

Read More

Towards a core outcome set for hemorrhoidal disease: a systematic review of outcomes reported in literature

2018

Kleijnen, J. et al.

Read More

Towards a core outcome set for hemorrhoidal disease: a systematic review of outcomes reported in literature

2018

van Tol, R.R.; van Zwietering, E.; Kleijnen, J.; Melenhorst, J.; Stassen, L.P.; Dirksen, C.D.; Breukink, S.O.

Int J Colorectal Dis; 33: 849-56.

Read More

Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease

2018

Hussein, N.; Weng, S.F.; Kai, J.; Kleijnen, J.; Qureshi, N.

Cochrane Database Syst Rev: CD010849 (3).

Read More

Trifluridine-tipiracil for previously treated metastatic colorectal cancer: an evidence review group perspective of a nice single technology appraisal

2018

Ramaekers, B.L.T.; Wolff, R.; van Giessen, A.; Pouwels, X.; Fayter, D.; Lang, S.; Armstrong, N.; Worthy, G.; Duffy, S.; Kleijnen, J.; Joore, M.A.

Pharmacoeconomics; 36: 285-8.

Read More

Pomalidomide with dexamethasone for treating relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib: an Evidence Review Group perspective of an NICE single technology appraisal

2018

Büyükkaramikli, N.C.; de Groot, S.; Fayter, D.; Wolff, R.; Armstrong, N.; Stirk, L.; Worthy, G.; Albuquerque de Almeida, F.; Kleijnen, J.; Al, M.J.

Pharmacoeconomics; 36: 145-59.

Read More

Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study

2017

Bramer, W.M; Rethlefsen, M.L; Kleijnen, J.; Franco, O.H.

Syst Rev; 6: 245.

Read More

Patient expectations for management of chronic non-cancer pain: a systematic review

2017

Geurts, J.W.; Willems, P.C.; Lockwood, C.; van Kleef, M.; Kleijnen, J.; Dirksen, C.

Health Expect; 35: 297-318.

Read More

Ramucirumab for treating advanced gastric cancer or gastro-oesophageal junction adenocarcinoma previously treated with chemotherapy: an Evidence Review Group perspective of a NICE Single Technology Appraisal

2017

Büyükkaramikli, N.C.; Blommestein, H.M.; Riemsma, R.; Armstrong, N.; Clay, F.J.; Ross, J.; Worthy, G.; Severens, J.; Kleijnen, J.; Al, M.J.

Pharmacoeconomics; 35: 1211-21.

Read More

Evaluation of a new method for librarian-mediated literature searches for systematic reviews

2017

Kleijnen, J. et al.

Read More

Evaluation of a new method for librarian-mediated literature searches for systematic reviews

2017

Bramer, W.M.; Rethlefsen, M.L.; Mast, F.; Kleijnen, J.

Research Synthesis Methods; 9: 510-20.

Read More

Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance

2017

Westwood, M.; Lang, S.; Armstrong, N.; van Turenhout, S.; Cubiella, J.; Stirk, L.; Corro Ramos, I.; Luyendijk, M.; Ziam, R.; Kleijnen, J.; Fraser, C.

BMC Med; 15: 189.

Read More

A proposed framework for developing quality assessment tools

2017

Whiting, P.; R., Wolff.; Mallett, S.; Simera, I.; Savovic, J.

Syst Rev; 6: 204.

Read More

Systematic review and network meta-analysis on the efficacy of evolocumab and other therapies for the management of lipid levels in hyperlipidemia

2017

Toth, P.P.; Worthy, G.; Gandra, S.R.; Sattar, N.; Bray, S.; Cheng, L.I.; Bridges, I.; Worth, G.M.; Dent, R.; Forbes, C.A.; Deshpande, S.; Ross, J.; Kleijnen, J.; Stroes, E.S.G.

J Am Heart Assoc; 6: pii: e005367.

Read More

Response to “Phrase truncation in PubMed searches”

2017

Duffy, S.; de Kock, S; Misso, K; Noake, C.; Ross, J.; Stirk, L

Journal of the Medical Library Association: JMLA; 105: 405-6.

Read More

Systematic reviews assessed as high risk of bias due to avoidable failures in searching: analysis of a data set of critically appraised systematic reviews

2017

Ross, J.; de Kock, S.; Stirk, L.; Noake, C.; Misso, K.; Duffy, S.

9th International Clinical Librarian Conference (ICLC), Leicester. 21-22 Sept 2017.

Read More

Assessing systematic review search methods for risk of bias (RoB): how to spot common inadequacies and errors in the conduct and reporting of search strategies. [Workshop]

2017

Misso, K.; Ross, J.; Noake, C.; De Kock, S.; Stirk, L.; Duffy, S.

9th International Clinical Librarian Conference (ICLC), Leicester: UK. 21-22 Sept 2017.

Read More

Systematic review of cure rates in incontinence – role of clinical experts

2017

Riemsma, R.; Deshpande, S.; Misso, K.; Hutt, E.; Huige, N.; Kleijnen, J.

Global Evidence Summit, Cape Town, South Africa. 13-16 Sep 2017.

Read More

Systematic reviews of prognostic studies III: PROBAST – A risk-of-bias tool for systematic reviews of prediction-modelling studies

2017

Ogilvie, R.; Moons, C.; Wolff, R.

Global Evidence Summit, Cape Town, South Africa. 13-16 Sep 2017.

Read More

Challenges of conducting a systematic review on the prevalence of rare diseases

2017

Leadley, R.; de Kock, S.; Lang, S.; Kleijnen, J.

Global Evidence Summit, Cape Town, South Africa. 13-16 Sep 2017.

Read More

Unnecessary pooling of heterogeneous data: analysis of a sample of systematic reviews

2017

Deshpande, S.; Westwood, M.; Misso, K.; Stirk, L.; de Kock, S.; Kleijnen, J.; Clayton, D.; Kleijnen, J.

Global Evidence Summit, Cape Town, South Africa. 13-16 Sep 2017.

Read More

Systematic reviews assessed as high risk of bias due to avoidable failures in searching: analysis of a data set of critically appraised systematic reviews

2017

de Kock, S.; Stirk, L.; Noake, C.; Deshpande, S.; Misso, K.; Kleijnen, J.; Duffy, S.

Global Evidence Summit, Cape Town, South Africa. 13-16 Sep 2017.

Read More
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

 

Kleijnen Systematic Reviews (KSR) Ltd is an independent research company that produces and disseminates systematic reviews, systematic literature reviews, cost-effectiveness analyses and health technology assessments of research evidence in healthcare. KSR Kleijnen Systematic Reviews Ltd works for a variety of commissioners, including the National Institute for Health and Care Excellence (NICE), similar institutes in Europe, and for pharmaceutical companies. Systematic literature reviews.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Kleijnen Systematic Reviews (KSR) Ltd is an independent research company that produces and disseminates systematic reviews, systematic literature reviews, cost-effectiveness analyses and health technology assessments of research evidence in healthcare.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

 

Kleijnen Systematic Reviews (KSR) Ltd is an independent research company that produces and disseminates systematic reviews, systematic literature reviews, cost-effectiveness analyses and health technology assessments of research evidence in healthcare.